Frederiksberg, Denmark

Rikke Nielsen


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Rikke Nielsen: A Pioneer in Tuberculosis Research

Introduction: Rikke Nielsen, hailing from Frederiksberg, Denmark, is a notable inventor whose work focuses on the advancement of research related to tuberculosis. With a patent portfolio that includes a significant invention, she has made a valuable contribution to the field of immunology and public health.

Latest Patents: Rikke Nielsen holds a patent titled "Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis." This groundbreaking invention is rooted in the identification and characterization of novel proteins and protein fragments. The patent details multiple sequences, including SEQ ID NOs: 2, 4, 6, 8, 10, 12, and many others. It encompasses polypeptides and their immunologically active fragments, the genes encoding them, as well as vaccines and skin test reagents that contain these polypeptides. A key element of her invention is the discovery that fusions between ESAT-6 and MPT59 provide superior immunogenicity compared to their individual counterparts.

Career Highlights: Rikke Nielsen has built her career within the esteemed Statens Serum Institut, where she has dedicated herself to vital research in immunology. Her pioneering work has the potential to lead to effective vaccines and diagnostics for tuberculosis, a disease that continues to pose a global health challenge.

Collaborations: Throughout her career, Rikke has collaborated with notable professionals in her field, including Peter Andersen and Thomas Oettinger. These partnerships have further enhanced her research and development efforts, driving innovation in the fight against tuberculosis.

Conclusion: Rikke Nielsen's contributions to the field of tuberculosis research exemplify the impact of innovative thinking and dedication to public health. With her patent on M. tuberculosis related fragments, she paves the way for future advancements in immunological treatments. Her work at Statens Serum Institut, bolstered by collaborations with fellow researchers, highlights the importance of teamwork in achieving scientific breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…